Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Tallman
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
mSystems
Evolution
Ecology
Genetics
Molecular Biology
Biochemistry
Systematics
Microbiology
Simulation
Computer Science Applications
Behavior
Modeling
Physiology
Protective Effect of Berberine on Renal Fibrosis Caused by Diabetic Nephropathy
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
SRT1720 Retards Renal Fibrosis via Inhibition of HIF1α /GLUT1 in Diabetic Nephropathy
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Antiatherosclerotic Effect of Farnesoid X Receptor
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Hepatic Carboxylesterase 1 Is Essential for Both Normal and Farnesoid X Receptor-Controlled Lipid Homeostasis
Hepatology
Medicine
Hepatology
LncRNA ZEB1-AS1 Was Suppressed by P53 for Renal Fibrosis in Diabetic Nephropathy
Molecular Therapy - Nucleic Acids
Drug Discovery
Molecular Medicine
CDK5 Promotes Renal Tubulointerstitial Fibrosis in Diabetic Nephropathy via ERK1/2/PPARγ Pathway
Oncotarget
Oncology
LncRNA NR_038323 Suppresses Renal Fibrosis in Diabetic Nephropathy by Targeting miR-324-3p/DUSP1 Axis
Molecular Therapy - Nucleic Acids
Drug Discovery
Molecular Medicine
Farnesoid X Receptor Suppresses Lgr5+ Cancer Stem Cell Proliferation
Cancer Discovery
Oncology
